Improving the drug development process by reducing the impact of adverse events: the case of cataracts considered

Andrew F Smith, Alexander Klotz, I. Michael Wormstone

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)
7 Downloads (Pure)

Search results